DEFROSIA 500 is a clinically trusted formulation of Deferasirox Dispersible Tablets 500 mg, specially designed for the management of chronic iron overload in patients who undergo frequent blood transfusions. In India, conditions like thalassemia, sickle cell anemia, and certain blood disorders often require repeated transfusions, which can gradually lead to excess iron accumulation in vital organs such as the liver, heart, and endocrine glands.
Iron overload, if left untreated, may result in serious complications, including liver damage, cardiac issues, and hormonal imbalance. DEFROSIA 500 works effectively by binding excess iron in the body and helping eliminate it through natural processes, thereby protecting organs and improving overall health outcomes.
This dispersible tablet is easy to administer, making it suitable for both pediatric and adult patients. With consistent use under medical supervision, DEFROSIA 500 supports long-term iron balance and enhances quality of life.
Uses of Deferasirox Dispersible Tablets 500 mg
DEFROSIA 500 is primarily prescribed for managing conditions related to iron overload. Below are the key uses:
Chronic Iron Overload Due to Blood Transfusions: Common in patients with thalassemia major and other transfusion-dependent anemias.
Non-Transfusion Dependent Thalassemia (NTDT) Helps control iron accumulation even in patients who do not receive frequent transfusions.
Sickle Cell Disease Used in patients receiving repeated transfusions to prevent iron toxicity.
Other Rare Blood Disorders Conditions like aplastic anemia or myelodysplastic syndromes where transfusions are required.
By effectively reducing excess iron levels, DEFROSIA 500 prevents long-term complications and improves patient prognosis.
Benefits
DEFROSIA 500 offers multiple therapeutic and patient-friendly benefits:
1. Effective Iron Chelation
The active ingredient deferasirox binds selectively to excess iron and facilitates its removal from the body, reducing toxic buildup.
2. Organ Protection
Chronic iron overload can damage major organs such as:
Liver
Heart
Endocrine glands
Regular use helps prevent these complications and supports long-term health.
3. Convenient Once-Daily Dosing
DEFROSIA 500 is typically taken once daily, making it easier for patients to adhere to treatment.
4. Dispersible Formulation
The tablet can be dissolved in water or juice, making it especially beneficial for:
Pediatric patients
Elderly individuals
Patients with swallowing difficulties
5. Improves Quality of Life
By maintaining optimal iron levels, patients experience:
Reduced fatigue
Better organ function
Improved overall well-being
6. Suitable for Long-Term Therapy
DEFROSIA 500 is designed for prolonged use under medical supervision, ensuring consistent control of iron levels.
Dosage of Deferasirox Dispersible Tablets 500 mg
The dosage of DEFROSIA 500 should always be determined by a qualified healthcare professional based on the patient’s condition, body weight, and iron levels.
General Dosage Guidelines:
Usually taken once daily on an empty stomach
Tablets should be dispersed in water, apple juice, or orange juice before consumption
Dose is often calculated based on body weight (mg/kg)
Important Instructions:
Do not swallow the tablet whole
Stir until completely dissolved before drinking
Take at the same time each day for better effectiveness
Regular monitoring of serum ferritin levels is required
Missed Dose:
If a dose is missed, take it as soon as remembered
Skip if it is close to the next dose
Do not double the dose
Proper adherence to dosage instructions ensures maximum therapeutic benefit and reduces the risk of complications.
Side Effects
Like all medications, DEFROSIA 500 may cause some side effects, although not everyone experiences them.
Common Side Effects:
Nausea
Vomiting
Diarrhea
Abdominal pain
Skin rash
Less Common but Serious Side Effects:
Increased liver enzymes
Kidney function abnormalities
Gastrointestinal bleeding
Hearing or vision disturbances (rare)
When to Seek Medical Attention:
Severe abdominal pain
Persistent vomiting
Yellowing of skin or eyes (jaundice)
Unusual fatigue or weakness
Regular monitoring and timely reporting of symptoms can help manage side effects effectively.
Precautions and Warnings
Before starting DEFROSIA 500, certain precautions should be considered to ensure safe and effective use:
1. Kidney Function Monitoring
Patients with pre-existing kidney issues should use this medication cautiously. Regular kidney function tests are recommended.
2. Liver Health
Since iron overload and its treatment both affect the liver, periodic liver function tests are essential.
3. Pediatric Use
It is safe and effective when prescribed appropriately for children but requires close monitoring.
4. Pregnancy and Breastfeeding
Use only if clearly recommended by a doctor
Discuss risks and benefits before starting treatment
5. Drug Interactions
Inform your doctor if you are taking:
Antacids containing aluminum
Certain antibiotics
Other iron chelators
6. Regular Blood Tests
Routine monitoring of:
Serum ferritin levels
Liver enzymes
Kidney function
is crucial for safe therapy.
7. Avoid Self-Medication
DEFROSIA 500 is a prescription medicine and should only be used under medical supervision.
Conclusion
DEFROSIA 500 Deferasirox Dispersible Tablets 500 mg is a highly effective solution for managing chronic iron overload in patients requiring repeated blood transfusions. With its advanced iron-chelating action, convenient dispersible form, and once-daily dosing, it offers both efficacy and ease of use.
By reducing excess iron levels, DEFROSIA 500 plays a vital role in protecting vital organs, preventing complications, and improving the overall quality of life for patients suffering from transfusion-dependent conditions. When used responsibly under medical guidance, it serves as a reliable and long-term therapeutic option in iron overload management.
For healthcare providers, distributors, and patients seeking a dependable iron chelation therapy, DEFROSIA 500 stands out as a trusted and clinically effective choice in the Indian pharmaceutical market.
